Electroacupuncture at Zusanli (ST-36) to help heal diabetic foot ulcers
Official title: Clinical Observation and Mechanism Study on the Therapeutic Effect of Electroacupuncture at Zusanli (ST-36) in Promoting Diabetic Foot Wound Healing Through Mediating Macrophage Polarization
Run by Zhongda Hospital · NCT07482137 · Data updated 2026-11-12
This will see if adding electroacupuncture at the Zusanli (ST-36) point to standard wound and diabetes care helps heal diabetic foot ulcers in adults.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 76 (estimated) |
| Sponsor | Zhongda Hospital Academic / other |
| Locations | 1 site (Nanjing, Jiangsu) |
| Status | Recruiting |
| Started | July 15, 2025 |
| Main results expected | September 30, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | March 19, 2026 |
| Trial ID | NCT07482137 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults 18–75 with Wagner grade 1–3 diabetic foot ulcers (2–30 cm²) who meet the study’s TCM blood-stasis criteria and have HbA1c below 9%.
✕Probably not a fit
Patients with HbA1c ≥ 9%, severe organ failure, active malignancy, psychiatric disorders, pregnancy, very large or gangrenous ulcers, or who cannot attend the study visits are unlikely to qualify or benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults with diabetic foot ulcers (Wagner grade 1–3, ulcer area 2–30 cm²) will be assigned to receive standard diabetes and wound care with or without additional electroacupuncture at the Zusanli (ST‑36) point. Standard care includes diabetes education, glucose control with insulin and/or oral agents, antibiotics if needed, regular wound cleaning and daily dressing changes, and drainage of abscesses when present. The electroacupuncture group will receive electrical stimulation at ST‑36 in addition to this care, and researchers will compare wound-healing outcomes between the groups over the study period. Eligible patients must also meet Traditional Chinese Medicine criteria for blood stasis obstructing the collateral pattern and have HbA1c below 9%.
Why it matters
Potential benefit: If effective, adding electroacupuncture could speed wound closure and reduce complications such as infection or amputation.
How similar studies have gone: Small clinical and animal studies have suggested acupuncture or electroacupuncture can improve local blood flow and wound healing, but large randomized trials are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Meet the diagnostic criteria for diabetic foot ulcers; 2. Meet the criteria for Traditional Chinese Medicine syndrome differentiation, classified as blood stasis obstructing the collateral pattern; 3. Wagner Grade 1-3, with ulcer area ranging from 2 cm² to 30 cm²; 4. Male or female, aged between 18 and 75 years; 5. Provide signed informed consent, voluntarily participate in this study, and demonstrate good compliance. Exclusion Criteria: 1. Complicated with severe diseases of the brain, liver, heart, lungs, or kidneys; 2. Pregnant women or women planning to become pregnant; 3. Glycosylated hemoglobin (HbA1c) level ≥ 9%; 4. Complicated with psychiatric disorders; 5. Complicated with genetic or infectious diseases, malignant tumors, or other severe conditions associated with a short life expectancy; 6. Concurrent participation in other clinical trials or participation within 4 weeks prior to randomization.
Where it's running
-
Zongda Hospital affiliated to Southeast University
Nanjing, Jiangsu, China Recruiting
Study contacts
- Study coordinator: Dachun Chen
- Email: peoplechenda@126.com
- Phone: 13912992162
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Nurse-led foot care education using the Health Belief Model for adults on hemodialysis
This program will test whether nurse-led foot care education based on the Health Belief Model helps adults with diabetes on hemodialysis improve foot care and lower their risk of foot ulcers.
-
Calcaneal Bone Marrow Cells in Foot/Ankle Surgery Patients
This observational study tests whether routine preoperative blood tests relate to the quality and behavior of mesenchymal stem cells from calcaneal bone marrow in adults undergoing foot or ankle surgery.
-
Semaglutide to help heal foot ulcers in people with type 2 diabetes
This 20-week randomized, double-blind trial will try semaglutide versus placebo to see if it helps heal foot ulcers in adults with type 2 diabetes.
-
Single-layer placental graft plus standard care for stubborn diabetic foot ulcers
This trial will try a single-layer placental-based graft together with usual wound care for adults whose diabetic foot ulcers did not heal after standard treatment in an earlier trial.
-
Wound matrix treatments for nonhealing diabetic foot ulcers
This trial will test whether adding special wound matrix products to standard care helps close hard-to-heal diabetic foot ulcers in adults with type 1 or 2 diabetes within 12 weeks.
-
Using stem cells from fat to treat diabetic foot ulcers
This study is testing if using stem cells from fat, along with a special blood product, can help heal chronic foot ulcers in people with diabetes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.